World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
71
Citations
21532
World Ranking
2294
National Ranking
1112

Jacques Galipeau publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Jacques Galipeau sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 361 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Jacques Galipeau D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Jacques Galipeau sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 71 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Jacques Galipeau is affiliated with the University of Wisconsin-Madison in the United States. Their research primarily focuses on the field of Medicine, with substantial contributions to several subfields, including Genetics, Oncology, Surgery, Immunology, and Physiology.

The scientist's main topics of study revolve around mesenchymal stem cell research, with additional attention to cancer cells and metastasis, salivary gland disorders and functions, tissue engineering and regenerative medicine, pancreatic function and diabetes, biomedical ethics and regulation, and head and neck cancer studies.

Jacques Galipeau has published extensively, with frequent appearances in journals such as Cytotherapy, Cancer Research, Biology of Blood and Marrow Transplantation, Frontiers in Immunology, and Science Advances. Cytotherapy stands out as the venue with the highest number of publications by this researcher.

Among their recent papers are:

  • CCL2 and CXCL12 Derived from Mesenchymal Stromal Cells Cooperatively Polarize IL-10+ Tissue Macrophages to Mitigate Gut Injury, 2020, Cell Reports
  • Macrophages at the Nexus of Mesenchymal Stromal Cell Potency: The Emerging Role of Chemokine Cooperativity, 2021, Stem Cells
  • Mesenchymal stromal cell therapeutic potency is dependent upon viability, route of delivery, and immune match, 2020, Blood Advances
  • Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition, 2021, Cytotherapy
  • Improving mesenchymal stem/stromal cell potency and survival, 2020, Cytotherapy

Jacques Galipeau collaborates frequently with other researchers. Notable coauthors include Iván Martín, Rachele Ciccocioppo, Miguel Forte, Bruce L. Levine, and Bernd Giebel.

Best Publications

  • Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities

    Jacques Galipeau;Luc Sensébé

  • Marrow stromal cells for cellular cardiomyoplasty: Feasibility and potential clinical advantages

    Jih Shiuan Wang;Dominique Shum-Tim;Jacques Galipeau;Edgar G. Chedrawy

  • Human MSC suppression correlates with cytokine induction of indoleamine 2,3-dioxygenase and bystander M2 macrophage differentiation.

    Moïra François;Raphaëlle Romieu-Mourez;Raphaëlle Romieu-Mourez;Mengyang Li;Jacques Galipeau;Jacques Galipeau

  • Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature.

    S. Viswanathan;Y. Shi;Y. Shi;J. Galipeau;M. Krampera

  • Allogeneic marrow stromal cells are immune rejected by MHC class I– and class II–mismatched recipient mice

    Nicoletta Eliopoulos;John Stagg;Laurence Lejeune;Sandra Pommey

  • The mesenchymal stromal cells dilemma—does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?

    Jacques Galipeau

  • International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials

    Jacques Galipeau;Mauro Krampera;John Barrett;Francesco Dazzi

  • Immunological characterization of multipotent mesenchymal stromal cells--The International Society for Cellular Therapy (ISCT) working proposal.

    Mauro Krampera;Jacques Galipeau;Yufang Shi;Karin Tarte

  • Airway delivery of mesenchymal stem cells prevents arrested alveolar growth in neonatal lung injury in rats.

    Timothy van Haaften;Roisin Byrne;Sebastien Bonnet;Gael Y. Rochefort

  • Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner

    Moutih Rafei;Philippe M. Campeau;Adriana Aguilar-Mahecha;Marguerite Buchanan

  • Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing

    Moïra François;Moïra François;Ian Bruce Copland;Shala Yuan;Raphaëlle Romieu-Mourez

  • Interferon-γ-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell

    John Stagg;Sandra Pommey;Sandra Pommey;Nicoletta Eliopoulos;Nicoletta Eliopoulos;Jacques Galipeau;Jacques Galipeau

  • Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation.

    Borhane Annabi;Ying‐Ta Lee;Sandra Turcotte;Emmanuelle Naud

  • Cytokine Modulation of TLR Expression and Activation in Mesenchymal Stromal Cells Leads to a Proinflammatory Phenotype

    Raphaëlle Romieu-Mourez;Moïra François;Marie-Noëlle Boivin;Manaf Bouchentouf

  • Therapeutic angiogenesis using autologous bone marrow stromal cells: improved blood flow in a chronic limb ischemia model.

    Abdulaziz Al-Khaldi;Hilal Al-Sabti;Jacques Galipeau;Kevin Lachapelle

  • Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo

    A Al-Khaldi;N Eliopoulos;D Martineau;L Lejeune

  • IDO-Independent Suppression of T Cell Effector Function by IFN-γ–Licensed Human Mesenchymal Stromal Cells

    Raghavan Chinnadurai;Ian B. Copland;Seema R. Patel;Jacques Galipeau

  • Regulation of MHC Class II Expression and Antigen Processing in Murine and Human Mesenchymal Stromal Cells by IFN-γ, TGF-β, and Cell Density

    Raphaëlle Romieu-Mourez;Moïra François;Marie-Noëlle Boivin;John Stagg

  • Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction.

    Moutih Rafei;Jeremy Hsieh;Simon Fortier;MengYang Li

  • Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication.

    Hong Qin;Qing Shao;Heather Curtis;Jacques Galipeau

Frequent Co-Authors

Greg Gibson
Greg Gibson Georgia Institute of Technology
Yufang Shi
Yufang Shi Soochow University
Donald G. Phinney
Donald G. Phinney Scripps Research Institute
Ivan Martin
Ivan Martin University Hospital of Basel
Brian P. Sorrentino
Brian P. Sorrentino St. Jude Children's Research Hospital
Luc Sensebé
Luc Sensebé StromaLab
Moulay A. Alaoui-Jamali
Moulay A. Alaoui-Jamali McGill University
David Lillicrap
David Lillicrap Queen's University
Subra Kugathasan
Subra Kugathasan Emory University
Ernesto L. Schiffrin
Ernesto L. Schiffrin McGill University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring allied healthcare fields can open diverse career opportunities. Many students begin with foundational programs such as easy lpn programs to get into, which offer a quick entry point into nursing and patient care. These programs can provide valuable clinical experience relevant to immunological healthcare settings.

For individuals without a nursing background, online rn programs for non nurses allow a smooth transition into registered nursing. Such pathways are ideal for science graduates who want to integrate immunology knowledge with hands-on nursing practice.

Accelerated options like absn programs with high acceptance rates enable faster degree completion for those holding non-nursing bachelor's degrees. This helps students quickly move into clinical roles supporting immunology research or patient care.

For advanced practice, pursuing accelerated fnp degrees combines specialized nursing skills with knowledge of immunology, preparing graduates for leadership roles in healthcare settings focused on immune-related conditions.

Best Scientists Citing Jacques Galipeau

Trending Scientists

Recently Published Articles